zstk474 and morpholine

zstk474 has been researched along with morpholine* in 2 studies

Other Studies

2 other study(ies) available for zstk474 and morpholine

ArticleYear
Structural effects of morpholine replacement in ZSTK474 on Class I PI3K isoform inhibition: Development of novel MEK/PI3K bifunctional inhibitors.
    European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

    Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Molecular Docking Simulation; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Primary Myelofibrosis; Protein Isoforms; Structure-Activity Relationship; Triazines

2022
Phosphatidylinositol 3-Kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: importance of the morpholine ring.
    Journal of medicinal chemistry, 2015, Jan-08, Volume: 58, Issue:1

    Phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related protein kinases (PIKKs) are two related families of kinases that play key roles in regulation of cell proliferation, metabolism, migration, survival, and responses to diverse stresses including DNA damage. To design novel efficient strategies for treatment of cancer and other diseases, these kinases have been extensively studied. Despite their different nature, these two kinase families have related origin and share very similar kinase domains. Therefore, chemical inhibitors of these kinases usually carry analogous structural motifs. The most common feature of these inhibitors is a critical hydrogen bond to morpholine oxygen, initially present in the early nonspecific PI3K and PIKK inhibitor 3 (LY294002), which served as a valuable chemical tool for development of many additional PI3K and PIKK inhibitors. While several PI3K pathway inhibitors have recently shown promising clinical responses, inhibitors of the DNA damage-related PIKKs remain thus far largely in preclinical development.

    Topics: Drug Design; Humans; Hydrogen Bonding; Molecular Structure; Morpholines; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Signal Transduction

2015